Analytica 2024: An Interview with Michael Lämmerhofer

During Analytica 2024 in Munich, Germany, Michael Lämmerhofer of the University of Tuebingen discusses the potential of chiral stationary phases (CSPs) in different applications.

Michael Lämmerhofer is a full professor (W3) for pharmaceutical (bio-)analysis at the University of Tübingen, Germany. H earned his PhD in Pharmaceutical Chemistry at the University of Graz, Austria. He was coworker of Professor W. Lindner (University of Vienna, Austria) until 2011 and from 1999 to 2000 he was post-doc at the Department of Chemistry of the University of California, Berkeley, USA, with Prof Frantisek Svec.

His research interests include the development of functionalized separation materials (chiral stationary phases, mixed‑mode phases, chemo- and bioaffinity materials, nanoparticles, monoliths), metabolomics and lipidomics, pharmaceutical analysis (impurity profiling, enantioselective analytics), multidimensional separations, and biopharmaceuticals analysis.

In this interview segment, Lämmerhofer discusses the following questions:

• Tell us a little bit about your presentation at Analytica.
• Chiral stationary phases (CSPs) are commonly associated with enantiomeric separation of chiral drugs. What other applications can they be used in?
• When it comes to real bioanalytical applications, chromatographic selectivity is usually combined with mass spectrometry (MS) to cope with assay-specificity limitations of CSPs. Can you describe some applications when combining CSPs with MS benefits the analyst?
• What benefits can incorporating CSPs into multidimensional chromatography offer the analyst and can you also illustrate this with some practical examples?
• What are you most looking forward to from the conference this week?

To learn more about Analytica 2024, you can watch more of our team's videos from the festival, where we interview people like Elia Psillakis of Technical University of Crete and Anne Bendt of the Singapore Lipidomics Incubator (SLING).